All Cosmos Bio-Tech Holding Corporation
TWSE:4148 株式レポート
All Cosmos Bio-Tech Holding マネジメント All Cosmos Bio-Tech Holdingの CEO はTony Pengで、 Sep2012年に任命され、 の在任期間は 12.17年です。 は、会社の株式の35.52%を直接所有しており、その価値はNT$ 1.18B 。経営陣と取締役会の平均在任期間はそれぞれ8.6年と2.4年です。
主要情報 CEO給与比率 n/a CEO在任期間 12.2yrs CEOの所有権 35.5% 経営陣の平均在職期間 8.6yrs 取締役会の平均在任期間 2.4yrs
経営陣の近況
All Cosmos Bio-Tech Holding Corporation, Annual General Meeting, Jun 21, 2024 Mar 27
All Cosmos Bio-Tech Holding Corporation Announces the Retirement of Ling Siu Hung as Chief Operating Officer Feb 01
High number of new directors Nov 16
High number of new directors Aug 01
High number of new directors Jul 01 All Cosmos Bio-Tech Holding Corporation Announces Change in Remuneration Committee
すべての更新を表示
All Cosmos Bio-Tech Holding Corporation to Report Q3, 2024 Results on Nov 12, 2024 Nov 05
Investor sentiment improves as stock rises 16% Oct 30
Second quarter 2024 earnings released: EPS: NT$0.12 (vs NT$0.61 in 2Q 2023) Aug 31
All Cosmos Bio-Tech Holding Corporation to Report Q2, 2024 Results on Aug 27, 2024 Aug 20
Upcoming dividend of NT$1.00 per share Jul 04
First quarter 2024 earnings released: EPS: NT$0.44 (vs NT$0.63 in 1Q 2023) May 19
Dividend of NT$1.00 announced May 15 All Cosmos Bio-Tech Holding Corporation to Report Q1, 2024 Results on May 13, 2024 May 05
New minor risk - Market cap size Apr 15
All Cosmos Bio-Tech Holding Corporation, Annual General Meeting, Jun 21, 2024 Mar 27
There May Be Reason For Hope In All Cosmos Bio-Tech Holding's (TWSE:4148) Disappointing Earnings Mar 22
Full year 2023 earnings released: EPS: NT$2.18 (vs NT$5.75 in FY 2022) Mar 19
All Cosmos Bio-Tech Holding Corporation Announces the Retirement of Ling Siu Hung as Chief Operating Officer Feb 01
Investor sentiment improves as stock rises 17% Dec 11
New minor risk - Earnings quality Nov 30
Third quarter 2023 earnings released: EPS: NT$1.07 (vs NT$2.48 in 3Q 2022) Nov 14
New minor risk - Earnings quality Sep 10
Second quarter 2023 earnings released: EPS: NT$0.61 (vs NT$1.47 in 2Q 2022) Aug 26
New minor risk - Market cap size Aug 11
Upcoming dividend of NT$2.50 per share at 4.1% yield Jul 03
Full year 2022 earnings released: EPS: NT$5.75 (vs NT$3.09 in FY 2021) Mar 28
Investor sentiment improves as stock rises 16% Feb 06
Third quarter 2022 earnings released: EPS: NT$2.48 (vs NT$0.76 in 3Q 2021) Nov 18
High number of new directors Nov 16
Investor sentiment deteriorated over the past week Oct 13
Investor sentiment deteriorated over the past week Sep 28
Second quarter 2022 earnings released: EPS: NT$1.47 (vs NT$0.66 in 2Q 2021) Sep 01
High number of new directors Aug 01
Investor sentiment improved over the past week Jul 25
Investor sentiment improved over the past week Jul 08
High number of new directors Jul 01 All Cosmos Bio-Tech Holding Corporation Announces Change in Remuneration Committee All Cosmos Bio-Tech Holding Corporation Approves Cash Dividends for 2021
Upcoming dividend of NT$1.50 per share Jun 16
First quarter 2022 earnings released: EPS: NT$1.07 (vs NT$0.42 in 1Q 2021) May 14
Investor sentiment deteriorated over the past week May 10
Price target increased to NT$102 Apr 27
Less than half of directors are independent Apr 27
Investor sentiment improved over the past week Apr 08
Full year 2021 earnings released: EPS: NT$3.09 (vs NT$1.28 in FY 2020) Mar 30
Investor sentiment improved over the past week Mar 14
Investor sentiment improved over the past week Feb 24
Third quarter 2021 earnings released: EPS NT$0.76 (vs NT$0.54 in 3Q 2020) Nov 12
Investor sentiment improved over the past week Oct 05
Second quarter 2021 earnings released: EPS NT$0.66 (vs NT$0.60 in 2Q 2020) Aug 31
Upcoming dividend of NT$1.00 per share Jun 29
First quarter 2021 earnings released: EPS NT$0.42 (vs NT$0.41 loss in 1Q 2020) May 14
All Cosmos Bio-Tech Holding Corporation Announces Cash Dividend, Payable on July 30, 2021 May 12
Is All Cosmos Bio-Tech Holding (TPE:4148) Using Too Much Debt? Apr 20
Price target decreased to NT$40.00 Apr 20
Acting for the Malaysian Subsidiary All Cosmos Bio-Tech Holding Corporation to Announce Temporary Shutdown of the Production Department Jan 22
Returns On Capital At All Cosmos Bio-Tech Holding (TPE:4148) Paint An Interesting Picture Jan 10
New 90-day high: NT$39.40 Jan 07
All Cosmos Bio-Tech Holding Corporation's (TPE:4148) Price Is Out Of Tune With Earnings Dec 22
Are Poor Financial Prospects Dragging Down All Cosmos Bio-Tech Holding Corporation (TPE:4148 Stock? Dec 01
Third quarter 2020 earnings released: EPS NT$0.54 Nov 13
New 90-day low: NT$33.80 Oct 29
First half earnings released Aug 14
CEO（最高経営責任者 Dato' Dr. Shih Hao Peng, also known as Tony, Ph.D. serves as Chief Executive Officer at ALL Cosmos Industries Sdn Bhd. He serves as the Chairman of the Board of All Cosmos Bio-Tech Holding Corporation and ... Show more
リーダーシップ・チーム 名称 ポジション 在職期間 報酬 所有権 Chairman of the Board & CEO 12.2yrs データなし 35.52% NT$ 1.2b Chief Financial Officer 8.6yrs データなし データなし AESB Chief Executive Officer less than a year データなし データなし
もっと見る
経験豊富な経営陣: 4148の経営陣は経験豊富で 経験豊富 です（平均在職期間は8.6年）。
取締役 名称 ポジション 在職期間 報酬 所有権 Chairman of the Board & CEO 14.7yrs データなし 35.52% NT$ 1.2b Non Independent Director 2.4yrs データなし データなし Representative Director 10.4yrs データなし 0.13% NT$ 4.3m Independent Director 10.4yrs データなし データなし Independent Director 5.4yrs データなし データなし Independent Director 2.4yrs データなし データなし Independent Director 2.4yrs データなし データなし Non Independent Director 2.4yrs データなし 0.017% NT$ 571.0k Non-Independent Director 2.4yrs データなし データなし
もっと見る
経験豊富なボード: 4148の 取締役会 は 経験豊富 ではない ( 2.4年の平均在任期間) ため、新しい取締役会が必要であると考えられます。
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
